Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension

被引:355
作者
Hocher, B
ThoneReineke, C
Rohmeiss, P
Schmager, F
Slowinski, T
Burst, V
Siegmund, F
Quertermous, T
Bauer, C
Neumayer, HH
Schleuning, WD
Theuring, F
机构
[1] FREE UNIV BERLIN,INST MOL BIOL & BIOCHEM,D-14195 BERLIN,GERMANY
[2] UNIV HEIDELBERG,KLINIKUM MANNHEIM,DEPT NEPHROL,D-68167 MANNHEIM,GERMANY
[3] SCHERING RES LABS,D-13342 BERLIN,GERMANY
[4] VANDERBILT UNIV,DIV CARDIOL,NASHVILLE,TN 37203
[5] HUMBOLDT UNIV BERLIN,DEPT NEPHROL,D-10098 BERLIN,GERMANY
关键词
human endothelin-1 transgenic mice; renal cysts; glomerular filtration rate; glomerulosclerosis; blood pressure;
D O I
10.1172/JCI119297
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The human endothelin-1 (ET-1) gene under the control of its natural promoter was transferred into the germline of mice, The transgene was expressed predominantly in the brain, lung, and kidney. Transgene expression was associated with a pathological phenotype manifested by signs such as age-dependent development of renal cysts, interstitial fibrosis of the kidneys, and glomerulosclerosis leading to a progressive decrease in glomerular filtration rate, This pathology developed in spite of only slightly elevated plasma and tissue ET-1 concentrations. Blood pressure was not affected even after the development of an impaired glomerular filtration rate, Therefore, these transgenic lines provide a new blood pressure-independent animal model of ET-1-induced renal pathology leading to renal fibrosis and fatal kidney disease.
引用
收藏
页码:1380 / 1389
页数:10
相关论文
共 35 条
  • [1] BAZIL MK, 1992, J CARDIOVASC PHARM, V20, P940, DOI 10.1097/00005344-199212000-00014
  • [2] A SPECIFIC ENDOTHELIN SUBTYPE-A RECEPTOR ANTAGONIST PROTECTS AGAINST INJURY IN RENAL-DISEASE PROGRESSION
    BENIGNI, A
    ZOJA, C
    CORNA, D
    ORISIO, S
    LONGARETTI, L
    BERTANI, T
    REMUZZI, G
    [J]. KIDNEY INTERNATIONAL, 1993, 44 (02) : 440 - 444
  • [3] BLOCH KD, 1989, J BIOL CHEM, V264, P10851
  • [4] CARONE FA, 1995, HISTOL HISTOPATHOL, V10, P213
  • [5] TUBULAR BASEMENT-MEMBRANE CHANGES DURING INDUCTION AND REGRESSION OF DRUG-INDUCED POLYCYSTIC KIDNEY-DISEASE
    CARONE, FA
    BUTKOWSKI, RJ
    NAKAMURA, S
    POLENAKOVIC, M
    KANWAR, YS
    [J]. KIDNEY INTERNATIONAL, 1994, 46 (05) : 1368 - 1374
  • [6] DISTRIBUTION AND FUNCTIONAL-ROLE OF RENAL ET RECEPTOR SUBTYPES IN NORMOTENSIVE AND HYPERTENSIVE RATS
    GELLAI, M
    DEWOLF, R
    PULLEN, M
    NAMBI, P
    [J]. KIDNEY INTERNATIONAL, 1994, 46 (05) : 1287 - 1294
  • [7] ENDOTHELIN RECEPTOR SUBTYPE-B MEDIATES SYNTHESIS OF NITRIC-OXIDE BY CULTURED BOVINE ENDOTHELIAL-CELLS
    HIRATA, Y
    EMORI, T
    EGUCHI, S
    KANNO, K
    IMAI, T
    OHTA, K
    MARUMO, F
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) : 1367 - 1373
  • [8] Hocher B, 1996, CARDIOVASC RES, V31, P499
  • [9] Characterization of the renal phenotype of transgenic rats expressing the human endothelin-2 gene
    Hocher, B
    Liefeldt, L
    ThoneReineke, C
    Orzechowski, HD
    Distler, A
    Bauer, C
    Paul, M
    [J]. HYPERTENSION, 1996, 28 (02) : 196 - 201
  • [10] Paracrine renal endothelin system in rats with liver cirrhosis
    Hocher, B
    Zart, R
    Diekmann, F
    Rohmeiss, P
    Distler, A
    Neumayer, HH
    Bauer, C
    Gross, P
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (02) : 220 - 227